A new study has revealed that a breakthrough mRNA-based vaccine could be a vital step toward finding a cure for HIV.
Researchers at the Fred Hutchinson Cancer Center in the United States discovered that 80% of volunteers developed antibodies capable of fighting HIV, signaling promising early results.
HIV currently affects nearly 41 million people worldwide, including over 30,000 in Australia. While antiretroviral therapy has helped manage the disease, a permanent cure remains elusive.
The new vaccine, developed using mRNA technology, may overcome long-standing challenges in HIV vaccine development.
Dr. Seth Cheetham, an mRNA expert from the University of Queensland, called the findings a major advancement. “This study marks significant progress in the global effort to develop a safe and effective HIV vaccine that prevents infection,” he said.
He emphasized the importance of further trials, noting that if results remain consistent in larger, real-world studies, mRNA vaccines could become a transformative weapon in the global fight against HIV—especially in high-prevalence regions like Botswana and South Africa.
